CARLSBAD, Calif.--(BUSINESS WIRE)--Isis Pharmaceuticals (NASDAQ: ISIS) announces the following Webcast: What: Isis Pharmaceuticals’ Ibis Division Analyst Day Webcast. Isis Pharmaceuticals management will highlight the Company’s Ibis Division and introduce commercial plans for the Ibis T5000 biosensor system. Company officials from our partner, Bruker Daltonics, will also present at the event.
